Cure51
France
- Paris
- 20/03/2024
- Seed
- $16,260,975
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
- Industry Biotechnology Research
- Website https://www.cure51.com/
- LinkedIn https://www.linkedin.com/company/cure51/
Related People
Nicolas WolikowFounder
France -
Greater Paris Metropolitan Region
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms.
Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees.
Managing P&L for business divisions exceeding $200M revenue.
Have been Chief Executive Officer, responsible for strategy implementation, business development and acquisitions initiatives. Currently Chief Digital Officer to transform a large organisation. Passionate about product innovations that shape new customer experiences.
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)